BioCentury
ARTICLE | Financial News

Follow-on roundup: Momenta, Dicerna

May 22, 2015 1:15 AM UTC

Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) and Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) raised a combined $186.6 million in follow-ons.

Biosimilars and complex generics developer Momenta raised $137.8 million through the sale of 7.3 million shares at $19. Underwriters were Goldman Sachs; JPMorgan; and Stifel. The company proposed the offering Monday after market close, when its shares were at $20.22. Momenta slipped $0.02 Wednesday after pricing the offering post-market on Tuesday; it regained $0.02 to $19.31 on Thursday. ...